Its interesting that the golden ticket held by ANP was worth US$125m for Sarepta back in 2017.
Its not going to pay for current trials but deal wise the voucher looks a lot like a golden goose. If I was the finance manager for one of those pharma companies who have an interest in the ATL1102 program, I would be be calculating the present value of US$125m in lieu of cash at bank in any takeover deal.
- Forums
- ASX - By Stock
- PER
- The Rome Cohort
The Rome Cohort, page-81
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
0.004(4.94%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $26.33K | 318.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 110919 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 136951 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 110919 | 0.083 |
1 | 50000 | 0.082 |
2 | 164616 | 0.081 |
5 | 215500 | 0.080 |
1 | 250000 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 136956 | 3 |
0.087 | 125000 | 1 |
0.089 | 102263 | 2 |
0.090 | 146175 | 1 |
0.091 | 108000 | 1 |
Last trade - 15.00pm 28/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online